Discover how the FDA’s Early Feasibility Studies (EFS) Program is revolutionizing medical device approvals in the U.S., and how MDIC is enhancing this process, in this insightful interview with Cyrano Therapeutics CEO Rick Geoffrion.
Category: News
MDIC In the News: MedTech Strategist
Discover how the FDA’s Early Feasibility Study (EFS) program is transforming U.S. clinical research and accelerating the development of innovative medical technologies.